Global Blood Therapeutics (GBT) Reports Q2 LPS of $0.58

August 10, 2016 4:08 PM EDT

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

Global Blood Therapeutics (NASDAQ: GBT) reported Q2 EPS of ($0.58), versus ($4.84) reported last year.

Cash and cash equivalents totaled $231.9 million at June 30, 2016 compared with $148.5 million at December 31, 2015.

For earnings history and earnings-related data on Global Blood Therapeutics (GBT) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities